Page 62 - TI Journal 18-1

56 COHEN

The diagnosis of mild cognitive impairment due Mintun, M.A. Molecular, structural, and func-
to Alzheimer’s disease: recommendations from tional characterization of Alzheimer’s disease:
the National Institute on Aging-Alzheimer’s evidence for a relationship between default
Association workgroups on diagnostic guidelines activity, amyloid, and memory. J. Neurosci.
for Alzheimer’s disease. Alzheimers Dement. 25(34):7709-7717; 2005.
7(3):270-279; 2011. 9. Busse, A.; Hensel, A.; Guhne, U.; Angermeyer, M.
3. Annus, T.; Wilson, L. R.; Hong, Y. T.; Acosta- C.; Riedel-Heller, S. G. Mild cognitive impair-
Cabronero, J.; Fryer, T. D.; Cardenas-Blanco, ment: long-term course of four clinical subtypes.
A.; Smith, R.; Boros, I.; Coles, J. P.; Aigbirhio, Neurology 67(12):2176-2185; 2006.
F. I.; Menon, D.K.; Zaman, S.H.; Nestor, P.J.; 10. Edison, P.; Archer, H. A.; Hinz, R.; Hammers,
Holland, A.J. The pattern of amyloid accumula- A.; Pavese, N.; Tai, Y. F.; Hotton, G.; Cutler, D.;
tion in the brains of adults with Down syndrome. Fox, N.; Kennedy, A.; Rossor, M.; Brooks, D.J.
Alzheimers Dement., in press.. Amyloid, hypometabolism, and cognition in
4. Archer, H. A.; Edison, P.; Brooks, D. J.; Barnes, J.; Alzheimer disease: an [11C]PIB and [18F]FDG
Frost, C.; Yeatman, T.; Fox, N. C.; Rossor, M. N. PET study. Neurology 68:501-508; 2006.
Amyloid load and cerebral atrophy in Alzheimer’s 11. Fagan, A. M.; Mintun, M. A.; Mach, R. H.; Lee,
disease: an 11C-PIB positron emission tomog- S. Y.; Dence, C. S.; Shah, A. R.; Larossa, G. N.;
raphy study. Ann. Neurol. 60(1):145-147; 2006. Spinner, M. L.; Klunk, W. E.; Mathis, C. A.;
5. Benzinger, T. L.; Blazey, T.; Jack, C. R., Jr.; Koeppe, DeKosky, S.T.; Morris, J.C.; Holtzman, D.M.
R. A.; Su, Y.; Xiong, C.; Raichle, M. E.; Snyder, Inverse relation between in vivo amyloid imag-
A. Z.; Ances, B. M.; Bateman, R. J.; Cairns, N.J.; ing load and cerebrospinal fluid Abeta(42) in
Fagan, A.M.; Goate, A.; Marcus, D.D.; Aisen, humans. Ann. Neurol. 59(3):512-519; 2006.
P.S.; Christensen, J.J.; Ercole, L.; Hornbeck, R.C.; 12. Fagan, A. M.; Roe, C. M.; Xiong, C.; Mintun, M.
Farrar, A.M.; Aldea, P.; Jasielec, M.S.; Owen, C.J.; A.; Morris, J. C.; Holtzman, D. M. Cerebrospinal
Xie, X.; Mayeux, R.; Brickman, A.; McDade, E.; fluid tau/beta-amyloid(42) ratio as a prediction
Klunk, W.; Mathis, C.A.; Ringman, J.; Thompson, of cognitive decline in nondemented older adults.
P.M.; Ghetti, B.; Saykin, A.J.; Sperling, R.A.; Arch. Neurol. 64(3):343-349; 2007.
Johnson, K.A.; Salloway, S.; Correia, S.; Schofield, 13. Forsberg, A.; Engler, H.; Almkvist, O.; Blomquist,
P.R.; Masters, C.L.; Rowe, C.; Villemagne, V.L.; G.; Hagman, G.; Wall, A.; Ringheim, A.;
Martins, R.; Ourselin, S.; Rossor, M.N.; Foz, N.C.; Langstrom, B.; Nordberg, A. PET imaging of
Cash, D.M.; Weiner, M.W.; Holtzman, D.M.; amyloid deposition in patients with mild cogni-
Buckles, V.D.; Moulder, K.; Morris, J.C. Regional tive impairment. Neurobiol. Aging 29(10):1456-
variability of imaging biomarkers in autosomal 1465; 2007.
dominant Alzheimer’s disease. Proc. Natl. Acad. 14. Gauthier, S.; Reisberg, B.; Zaudig, M.; Petersen, R.
Sci. U.S.A. 110(47):E4502-4509; 2013. C.; Ritchie, K.; Broich, K.; Belleville, S.; Brodaty,
6. Braak, H.; Braak, E. Alzheimer’s disease: striatal H.; Bennett, D.; Chertkow, H.; Cummings, J.L.;
amyloid deposits and neurofibrillary changes. de Leon, M.; Feldman, H.; Ganguli, M.; Hampel,
J. Neuropathol. Exp. Neurol. 49:215-224; 1990. H.; Scheltens, P.; Tierney, M.C.; Whitehouse, P.;
7. Brilliant, M. J.; Elble, R. J.; Ghobrial, M.; Struble, Winblad, B. Mild cognitive impairment. Lancet
R. G. The distribution of amyloid beta protein 367(9518):1262-1270; 2006.
deposition in the corpus striatum of patients 15. Handen, B. L.; Cohen, A. D.; Channamalappa, U.;
with Alzheimer’s disease. Neuropathol. Appl. Bulova, P.; Cannon, S. A.; Cohen, W. I.; Mathis,
Neurobiol. 23(4):322-325; 1997. C. A.; Price, J. C.; Klunk, W. E. Imaging brain
8. Buckner, R. L.; Snyder, A. Z.; Shannon, B. J.; amyloid in nondemented young adults with
LaRossa, G.; Sachs, R.; Fotenos, A. F.; Sheline, Down syndrome using Pittsburgh compound
Y. I.; Klunk, W. E.; Mathis, C. A.; Morris, J. C.; B. Alzheimers Dement. 8(6):496-501; 2012.